![]() |
|
|
Laboratorio de Radioisótopos, Facultad de Farmacia y Bioquímica (F.M., N.F., B.L.L., M.E.R., C.D.) and Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales (C.S.), Universidad de Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina (F.M., N.F., A.B., C.S., C.D.); and Instituto de Biología y Medicina Experimental, Buenos Aires, Argentina (N.F., A.B., C.S.)
Knowing the importance for research and pharmacological uses of proper
ligand classification into agonists, inverse agonists, and antagonists, the
aim of this work was to study the behavior of tiotidine, a controversial
histamine H2 receptor ligand. We found that tiotidine, described previously as
an H2 antagonist, actually behaves as an inverse agonist in U-937 cells,
diminishing basal cAMP levels. [3H]Tiotidine showed two binding
sites, one with high affinity and low capacity and the other with low affinity
and high capacity. The former site disappeared in the presence of guanosine
5'-O-(3-thio)triphosphate, indicating that it belongs to a
subset of receptors coupled to G-protein, showing the classic binding profile
for an agonist. Considering the occupancy models developed up to now, the only
one that explains tiotidine dual behavior is the cubic ternary complex (CTC)
model. This model allows G-protein to interact with the receptor even in the
inactive state. We showed by theoretical simulations based on the CTC model of
dose-response and binding experiments that tiotidine biases the system to a
G-proteincoupled form of the receptor that is unable to evoke a
response. This theoretical approach was supported by experimental results in
which an unrelated G-proteincoupled receptor that also signals through
G
s-protein (
2-adrenoreceptor) was impeded
by tiotidine. This interference clearly implies that tiotidine biases the
system to G
s-coupled form of the H2 receptor and turns
G
s-protein less available to interact with
2-adrenoreceptor. These findings not only show that tiotidine
is an H2 inverse agonist in U-937 cells but also provide experimental support
for the CTC model.
Address correspondence to: Dr. Davio Carlos, Laboratorio de Radioisótopos, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires. Junin 956 PB, 1113, Capital Federal, Argentina. E-mail: cardavio{at}ffyb.uba.ar
This article has been cited by other articles:
![]() |
G. Bongers, K. M. Krueger, T. R. Miller, J. L. Baranowski, B. R. Estvander, D. G. Witte, M. I. Strakhova, P. van Meer, R. A. Bakker, M. D. Cowart, et al. An 80-Amino Acid Deletion in the Third Intracellular Loop of a Naturally Occurring Human Histamine H3 Isoform Confers Pharmacological Differences and Constitutive Activity J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 888 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Amaral, C. Davio, A. Ceballos, G. Salamone, C. Canones, J. Geffner, and M. Vermeulen Histamine Improves Antigen Uptake and Cross-Presentation by Dendritic Cells J. Immunol., September 15, 2007; 179(6): 3425 - 3433. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-C. Kim, S.-Y. Choi, S.-H. Kim, B.-S. Yun, I.-D. Yoo, Nanga. R. P. Reddy, H. S. Yoon, and K.-T. Kim Isoliquiritigenin Selectively Inhibits H2 Histamine Receptor Signaling Mol. Pharmacol., August 1, 2006; 70(2): 493 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Dowling, J. M. Willets, D. C. Budd, S. J. Charlton, S. R. Nahorski, and R. A. J. Challiss A Single Point Mutation (N514Y) in the Human M3 Muscarinic Acetylcholine Receptor Reveals Differences in the Properties of Antagonists: Evidence for Differential Inverse Agonism J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1134 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Perez and S. S. Karnik Multiple Signaling States of G-Protein-Coupled Receptors Pharmacol. Rev., June 1, 2005; 57(2): 147 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Fitzsimons, F. Monczor, N. Fernandez, C. Shayo, and C. Davio Mepyramine, a Histamine H1 Receptor Inverse Agonist, Binds Preferentially to a G Protein-coupled Form of the Receptor and Sequesters G Protein J. Biol. Chem., August 13, 2004; 279(33): 34431 - 34439. [Abstract] [Full Text] [PDF] |
||||